James E. Bradner
Impact in
- Hematology top 0.05%
- Multiple Myeloma Research and Treatments
- Molecular Biology top 0.05%
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- Cancer-related gene regulation
Papers in
- Hematology 58
- Multiple Myeloma Research and Treatments 44
- Acute Myeloid Leukemia Research 16
-
- Protein Degradation and Inhibitors 142
- Ubiquitin and proteasome pathways 66
- Histone Deacetylase Inhibitors Research 65
- Genomics and Chromatin Dynamics 24
- Epigenetics and DNA Methylation 19
- Co-authors
- Richard A. YoungJun QiDennis L. BuckleyDenes HniszJoshiawa PaulkJustin M. RobertsRalph MazitschekCharles Y. Lin
- Journals
- Blood (31 papers)Cancer Research (16 papers)Cell (8 papers)Proceedings of the National Academy of Sciences (8 papers)Clinical Cancer Research (7 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
James E. Bradner
212 papers receiving 28.4k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Hematology 5.8k
- Molecular Biology 24.1k
- Oncology 6.3k
- Cancer Research 2.3k
- Genetics 1.3k
Countries citing papers authored by James E. Bradner
This map shows the geographic impact of James E. Bradner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Bradner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Bradner more than expected).
Fields of papers citing papers by James E. Bradner
This network shows the impact of papers produced by James E. Bradner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Bradner. The network helps show where James E. Bradner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James E. Bradner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 21 | |
| 2 | 2018 | 40 | |
| 3 | 2016 | 166 | |
| 4 | 2016 | 116 | |
| 5 | 2016 | 75 | |
| 6 | 2016 | 50 | |
| 7 | 2015 | 110 | |
| 8 | 2015 | 59 | |
| 9 | Phthalimide conjugation as a strategy for in vivo target protein degradation Hit paper breakdown → | 2015 | 1253 |
| 10 | 2014 | 155 | |
| 11 | 2014 | 116 | |
| 12 | 2014 | 112 | |
| 13 | 2014 | 12 | |
| 14 | 2014 | 27 | |
| 15 | 2014 | 45 | |
| 16 | Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition Hit paper breakdown → | 2013 | 457 |
| 17 | 2012 | 276 | |
| 18 | 2012 | 210 | |
| 19 | PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to Gefitinib Hit paper breakdown → | 2007 | 598 |
| 20 | Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies Hit paper breakdown → | 2007 | 699 |
About James E. Bradner
James E. Bradner is a scholar working on Hematology, Molecular Biology, Oncology, Virology and Cancer Research, having authored 217 papers that have together received 28.8k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (142 papers), Ubiquitin and proteasome pathways (66 papers), Histone Deacetylase Inhibitors Research (65 papers), Multiple Myeloma Research and Treatments (44 papers), Genomics and Chromatin Dynamics (24 papers), Peptidase Inhibition and Analysis (20 papers), Epigenetics and DNA Methylation (19 papers) and Acute Myeloid Leukemia Research (16 papers). The work is most often cited by research in Hematology (5.8k citations), Molecular Biology (24.1k citations), Oncology (6.3k citations), Cancer Research (2.3k citations) and Genetics (1.3k citations). James E. Bradner has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Richard A. Young, Jun Qi, Dennis L. Buckley, Denes Hnisz, Joshiawa Paulk, Justin M. Roberts, Ralph Mazitschek, Charles Y. Lin, Tong Ihn Lee and Sirano Dhe‐Paganon. Their work appears in journals such as Blood, Cancer Research, Cell, Proceedings of the National Academy of Sciences and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.